Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab Plus Methotrexate on Work Disability in Early Rheumatoid Arthritis
NCT00234845Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Mar 2003
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of adalimumab in rheumatoid arthritis (RA), sponsored by Abbott Laboratories. Started Mar 2003; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00234845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00234845.